Company Filing History:
Years Active: 2014
Title: Niko Bausch: Innovator in Tumor Response Prediction
Introduction
Niko Bausch is a prominent inventor based in Freiburg, Germany. She has made significant contributions to the field of oncology through her innovative research and development. Her work focuses on understanding how tumors respond to pharmaceutical compounds, which is crucial for personalized medicine.
Latest Patents
Niko Bausch holds a patent titled "Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds." This invention relates to a method for providing a gene expression profile that predicts the specific response of an individual tumor to a pharmaceutical compound. The patent includes the use of a microarray containing nucleotide sequences corresponding to predictive genes and a diagnostic kit that incorporates this microarray.
Career Highlights
Niko Bausch is associated with Oncotest GmbH, where she applies her expertise in tumor biology and gene expression analysis. Her work at the company has been instrumental in advancing the understanding of tumor responses to treatments.
Collaborations
Some of her notable coworkers include Heinz-Herbert Fiebig and André Korrat, who collaborate with her on various research projects aimed at improving cancer treatment strategies.
Conclusion
Niko Bausch's innovative work in predicting tumor responses through gene expression profiles represents a significant advancement in personalized medicine. Her contributions continue to impact the field of oncology positively.